Stockscreener 앱 받기
1.85
5.71%
0.10
시간 외 거래:
1.86
0.01
+0.54%
전일 마감가:
$1.75
열려 있는:
$1.76
하루 거래량:
919.70K
Relative Volume:
0.57
시가총액:
$139.22M
수익:
$302.48M
순이익/손실:
$-265.26M
주가수익비율:
-0.4978
EPS:
-3.716
순현금흐름:
$-2.76M
1주 성능:
+6.94%
1개월 성능:
-19.21%
6개월 성능:
+0.54%
1년 성능:
-36.75%
1일 변동 폭
$1.76
$1.885
1주일 범위
$1.68
$1.885
52주 변동 폭
$0.9551
$3.80
Health Catalyst Inc Stock (HCAT) Company Profile
명칭
Health Catalyst Inc
전화
801-708-6800
주소
10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN
Compare HCAT vs VEEV, BTSG, TEM, HQY, TXG
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HCAT
Health Catalyst Inc
|
1.85 | 134.71M | 302.48M | -265.26M | -2.76M | -3.716 |
VEEV
Veeva Systems Inc
|
243.75 | 39.23B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
61.71 | 11.81B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
52.10 | 9.85B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
104.73 | 8.82B | 1.34B | 230.70M | 440.96M | 2.6695 |
TXG
10 X Genomics Inc
|
56.09 | 7.52B | 638.78M | -22.66M | 122.18M | -0.1744 |
Health Catalyst Inc Stock (HCAT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-18 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2025-08-27 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2025-08-11 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-08-08 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2025-06-17 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2025-04-09 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2025-01-08 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-04-10 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-01-03 | 개시 | Barclays | Overweight |
| 2024-01-03 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2023-12-13 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2023-11-13 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2023-08-01 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-05-10 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2023-05-10 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2023-04-20 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-04-12 | 개시 | Stephens | Equal-Weight |
| 2023-04-04 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2023-01-03 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2022-10-31 | 개시 | Wells Fargo | Equal Weight |
| 2022-10-25 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-09-16 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2022-09-13 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-08-05 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-08-05 | 다운그레이드 | Stifel | Buy → Hold |
| 2022-04-14 | 개시 | Guggenheim | Buy |
| 2022-03-17 | 업그레이드 | Jefferies | Hold → Buy |
| 2022-02-11 | 개시 | Goldman | Buy |
| 2021-12-02 | 개시 | Jefferies | Hold |
| 2021-10-14 | 개시 | BTIG Research | Buy |
| 2021-04-29 | 재개 | JP Morgan | Overweight |
| 2020-12-08 | 개시 | Berenberg | Buy |
| 2020-07-14 | 개시 | Citigroup | Buy |
| 2020-06-18 | 개시 | Stifel | Buy |
| 2020-06-15 | 재개 | Evercore ISI | Outperform |
| 2020-05-15 | 개시 | Guggenheim | Buy |
| 2020-04-21 | 개시 | RBC Capital Mkts | Outperform |
| 2020-04-13 | 개시 | SVB Leerink | Outperform |
| 2020-04-02 | 개시 | Canaccord Genuity | Buy |
| 2019-12-20 | 개시 | Raymond James | Strong Buy |
| 2019-10-30 | 개시 | Cantor Fitzgerald | Overweight |
| 2019-08-19 | 개시 | Evercore ISI | Outperform |
| 2019-08-19 | 개시 | Goldman | Buy |
| 2019-08-19 | 개시 | JP Morgan | Overweight |
| 2019-08-19 | 개시 | Piper Jaffray | Overweight |
| 2019-08-19 | 개시 | SVB Leerink | Outperform |
| 2019-08-19 | 개시 | SunTrust | Buy |
| 2019-08-19 | 개시 | William Blair | Outperform |
모두보기
Health Catalyst Inc 주식(HCAT)의 최신 뉴스
5 Must-Read Analyst Questions From Health Catalyst’s Q2 Earnings Call - Yahoo Finance
Health Catalyst (HCAT) group led by Clint Coghill reports 9.6% ownership stake - Stock Titan
Health Catalyst (HCAT) Q2 2026 Earnings Call Transcript - AOL.com
HCAT Maintains by Wells Fargo -- Price Target Lowered to $1.50 - GuruFocus
Wells Fargo & Company Has Lowered Expectations for Health Catalyst (NASDAQ:HCAT) Stock Price - MarketBeat
Health Catalyst, Inc. (NASDAQ:HCAT) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Health Catalyst: Q2 Earnings Snapshot - AOL.com
HCAT Maintained by Citigroup -- Price Target Lowered to $2.00 - GuruFocus
Health Catalyst (NASDAQ:HCAT) Price Target Cut to $2.00 by Analysts at Citigroup - MarketBeat
HCAT Q2 Deep Dive: Vitalware Divestiture Reshapes Strategy Amid Revenue Decline - Yahoo Finance
Health Catalyst Inc (HCAT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Why Health Catalyst (HCAT) Shares Are Trading Lower Today - Yahoo Finance
Health Catalyst (NASDAQ:HCAT) Issues Quarterly Earnings Results, Beats Estimates By $0.01 EPS - MarketBeat
Health Catalyst Shares Tumble Overnight: What Investors Need to Know - webull.com
Health Catalyst, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Health Catalyst sells Vitalware unit, retires credit facility By Investing.com - Investing.com Nigeria
Health Catalyst Inc (HCAT) (Q2 2026) Earnings Call Highlights: D - GuruFocus
Health Catalyst 2Q Loss $40.5M >HCAT - Moomoo
Is Health Catalyst Inc (HCAT) Positioned for Recovery After Q2 E - GuruFocus
Health Catalyst Q2 Earnings Call Highlights - MarketBeat
HCAT Looks 53.0% Undervalued on GF Value™ Despite Earnings Chall - GuruFocus
Earnings call transcript: Health Catalyst posts Q2 2026 revenue beat, shares sink - Investing.com
Health Catalyst sells Vitalware unit, retires credit facility - Investing.com
Compared to Estimates, Health Catalyst (HCAT) Q2 Earnings: A Look at Key Metrics - Yahoo Finance
Health Catalyst, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Health Catalyst (HCAT) Beats Q2 Earnings and Revenue Estimates - Yahoo Finance
M&A: Health Catalyst Closes $147M Sale of Vitalware to Med-Metrix - HIT Consultant
Health Catalyst, Inc. 2026: Revenue $70.49M, EPS ($0.55) — 10-Q Summary - TradingView
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Health Catalyst (NASDAQ:HCAT) Exceeds Q2 CY2026 Expectations But Stock Drops 25.5% - Barchart.com
Q2 2026 Health Catalyst Inc Earnings Call Transcript - GuruFocus
Health Catalyst (NASDAQ: HCAT) books $151.6M loss and $147M Vitalware sale - Stock Titan
HEALTH CATALYST ($HCAT) Releases Q2 2026 Earnings - quiverquant.com
Health Catalyst Reports Second Quarter 2026 Results - The Manila Times
Health Catalyst (Nasdaq: HCAT) sells Vitalware, ends credit facility debt - Stock Titan
Health Catalyst, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Health Catalyst Completes Sale of Vitalware, Sharpening Its Focus as a Healthcare Intelligence Company - marketscreener.com
BRIEF-Health Catalyst Q2 Net Income USD -40.537 Million - TradingView
Health Catalyst, Inc. Reports Impairment Charges for the Second Quarter Ended June 30, 2026 - marketscreener.com
Health Catalyst Tries To Reset With A Vitalware Sale - Finimize
Health Catalyst (HCAT) Q2 Earnings Report Preview: What To Look For - Barchart.com
Health Catalyst, Inc. expected to post earnings of 3 cents a shareEarnings Preview - TradingView
nCino, Braze, ServiceNow, Health Catalyst, and Palo Alto Networks Shares Are Soaring, What You Need To Know - Yahoo Finance
Med-Metrix, LLC completed the acquisition of Vitalware, LLC from Health Catalyst, Inc.. - marketscreener.com
Health Catalyst (NASDAQ:HCAT) Results Put Execution in Focus - Kalkine Media
MidCap Advisors Advises Leading Midwest Psychiatric Care Provider in Its Acquisition by Health Catalyst Capital - Yahoo Finance Singapore
Health Catalyst Inc (HCAT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
HCAT|Health Catalyst Inc|Price:2.150|Chg%:+0.070 - TradingKey
Health Catalyst Inc (HCAT) Institutional Confidence - TradingKey
Health Catalyst Inc (HCAT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
BlackRock (NYSE: BLK) holds 1.5% beneficial stake in Health Catalyst (HCAT) - Stock Titan
Health Catalyst Inc (HCAT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.10%
6.73%
자본화:
|
볼륨(24시간):